ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2517

Primary Sjögren’s Syndrome and Pregnancy: Evolution of Thyroid Function, Xerostomia, Xerophthalmia and Salivary Test for Dental Caries Risk

Elisa Trujillo1, Maria del Mar Trujillo2, Erica Padron3, Maria Garcia-Gonzalez4, Lorena Exposito5, Hiurma Sanchez5 and Sandra Garcia6, 1Hospital Universitario de Canarias, Servicio de Reumatologia, Tenerife, Spain, 2Servicio Canario de Salud., Servicio de Evaluación de tecnología Sanitaria, santa cruz de Tenerife, Spain, 3Hospital Universitario de Canarias, Servicio de Ginecología y Obstetricia., santa cruz de Tenerife, Spain, 4Rheumatology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 5Hospital Universitario de Canarias, Servicio de Reumatologia, santa cruz de Tenerife, Spain, 6Bow lane dental Group, Dentist, London, England

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: dry eyes, pregnancy, salivary hypofunction and thyroid, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Reproductive Issues in Rheumatic Disorders: Basic and Clinical Aspects Poster Session

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: 1. To study the effect of pregnancy in PSS patients on oral and ocular dryness and the salivary test for dental caries activity. 2. To study the effect of pregnancy on thyroid function in PSS patients with positive anti-thyroid antibodies (anjti-thyroglobulin and / or anti-peroxidase).

Methods: A prospective study was conducted throughout pregnancy in 12 PSS patients.

The following tests were performed at first visit and then monthly until the end of pregnancy: Schirmer tear secretion test; Whole saliva test (Heintze et al); Questionnaire on oral symptoms (Neidermaier 1998); Questionnaire on dry-eye symptoms (DEQ) (Begley et al). 

To test dental caries activity, saliva samples were obtained from all patients during the first month of pregnancy and again at 3, 6 and 9 months. The following tests were performed: CRT® Buffer test was used to determine the buffering capacity of saliva to reduce pH changes; Alban® test) (0-4) was used to measure the ability of saliva to produce acid because of the microorganisms it contains; CRT bacteria system for LB and SM® was used to measure salivary levels of Lactobacillus (LB) and Streptococcus mutans(SM).

Thyroid function was prospectively studied during pregnancy in those PSS patients with positive anti-thyroglobulin and / or anti-peroxidase antibodies (n=10).  At the first visit, then monthly to the end of pregnancy, TSH and free T4 were measured in all patients.

Results:

1. No significant changes in Schirmer test or whole saliva test results were observed during pregnancy. No significant changes were observed in the results of the two questionnaires.

2. The results of caries activity tests are presented in the table below:

 

Patients with PSS during pregnancy (n=12)

1 month

3 months

6 months

9 months

CRT buffer (pH) – mean (SD)

4.9 (0.5)

4.6 (1.1)

4.3 (0.6)

4.0 (1.0)

Alban test (0-4) – mean (SD)

3.2 (0.3)

3.4 (0.4)

3.4 (0.6)

3.6 (1.1)

CRT bacteria for LB

(% patients with levels ≥100.000 CFUs/mL saliva)

73.2

81.2

81.8

84.4

CRT bacteria for MS

(% patients with levels ≥100.000 CFUs/mL saliva)

69.5

70.1

82.9

83.3

3. Four patients presented normal physiological changes in thyroid function during pregnancy. Three patients showed higher than normal TSH levels while maintaining normal free T4 levels. Three patients had elevated free T4 during pregnancy. Five patients were prescribed treatment with levothyroxine to maintain TSH levels within the range recommended during pregnancy.

Conclusion:

Pregnancy did not significantly alter the characteristics of xerophthalmia and xerostomia in patients with primary SS. However, periodic salivary tests for dental caries risk showed a gradual decline in the buffering capacity of these patients’ saliva, as well as an increase ability to produce acid. The proportion of patients with high SM and LB values also increased as pregnancy progressed.

The presence of anti-thyroid antibodies, a common finding in patients with PSS, is a risk factor for the development of hypothyroidism during pregnancy.


Disclosure: E. Trujillo, None; M. D. M. Trujillo, None; E. Padron, None; M. Garcia-Gonzalez, None; L. Exposito, None; H. Sanchez, None; S. Garcia, None.

To cite this abstract in AMA style:

Trujillo E, Trujillo MDM, Padron E, Garcia-Gonzalez M, Exposito L, Sanchez H, Garcia S. Primary Sjögren’s Syndrome and Pregnancy: Evolution of Thyroid Function, Xerostomia, Xerophthalmia and Salivary Test for Dental Caries Risk [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/primary-sjogrens-syndrome-and-pregnancy-evolution-of-thyroid-function-xerostomia-xerophthalmia-and-salivary-test-for-dental-caries-risk/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/primary-sjogrens-syndrome-and-pregnancy-evolution-of-thyroid-function-xerostomia-xerophthalmia-and-salivary-test-for-dental-caries-risk/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology